Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors

被引：60
|
作者：
Thomas, Anusha S. [1 ]
Ma, Weijie [2 ]
Wang, Yinghong [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Zhongnan Hosp, Wuhan, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 06期
关键词：
D O I：
10.1056/NEJMc2031717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Two patients in whom severe refractory autoimmune colitis developed after cancer treatment with immune checkpoint inhibitors had a response to a course of subcutaneously administered ustekinumab, an antibody that blocks interleukin-12/23 signaling.
引用
收藏
页码：581 / 583
页数：3
相关论文
共 50 条
  • [1] Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
    Del Nogal, Genesis Perez
    Patel, Neha
    [J]. ACG CASE REPORTS JOURNAL, 2022, 9 (12)
  • [2] Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors
    Malik, Alexander
    Yousaf, Muhammad N.
    Samiullah, Sami
    Tahan, Veysel
    Mahdi, Amin
    [J]. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2023, 13 (03): : 75 - 78
  • [3] Overlapping Hepatotoxicity and Colitis Associated With Immune Checkpoint Inhibitors
    Malik, Alexander
    Yousaf, Muhammad Nadeem
    Samiullah, Sami
    Veysel, Tahan
    Sun, Yuchu
    Mahdi, Amin
    Basar, Omer
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2007 - S2008
  • [4] Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis
    Klemm, Natasha
    Trasolini, Roberto
    Chahal, Daljeet
    Donnellan, Fergal
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [5] Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
    Wang, Yinghong
    Wiesnoski, Diana H.
    Helmink, Beth A.
    Gopalakrishnan, Vancheswaran
    Choi, Kati
    DuPont, Hebert L.
    Jiang, Zhi-Dong
    Abu-Sbeih, Hamzah
    Sanchez, Christopher A.
    Chang, Chia-Chi
    Parra, Edwin R.
    Francisco-Cruz, Alejandro
    Raju, Gottumukkala S.
    Stroehlein, John R.
    Campbell, Matthew T.
    Gao, Jianjun
    Subudhi, Sumit K.
    Maru, Dipen M.
    Blando, Jorge M.
    Lazar, Alexander J.
    Allison, James P.
    Sharma, Padmanee
    Tetzlaff, Michael T.
    Wargo, Jennifer A.
    Jenq, Robert R.
    [J]. NATURE MEDICINE, 2018, 24 (12) : 1804 - +
  • [6] Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
    Yinghong Wang
    Diana H. Wiesnoski
    Beth A. Helmink
    Vancheswaran Gopalakrishnan
    Kati Choi
    Hebert L. DuPont
    Zhi-Dong Jiang
    Hamzah Abu-Sbeih
    Christopher A. Sanchez
    Chia-Chi Chang
    Edwin R. Parra
    Alejandro Francisco-Cruz
    Gottumukkala S. Raju
    John R. Stroehlein
    Matthew T. Campbell
    Jianjun Gao
    Sumit K. Subudhi
    Dipen M. Maru
    Jorge M. Blando
    Alexander J. Lazar
    James P. Allison
    Padmanee Sharma
    Michael T. Tetzlaff
    Jennifer A. Wargo
    Robert R. Jenq
    [J]. Nature Medicine, 2018, 24 : 1804 - 1808
  • [7] Immune Checkpoint Inhibitors-Induced Colitis
    Tian, Yun
    Abu-Sbeih, Hamzah
    Wang, Yinghong
    [J]. IMMUNOTHERAPY, 2ND EDITION, 2018, 995 : 151 - 157
  • [8] Immune Checkpoint Inhibitors in Patients With Microscopic Colitis
    Farha, Natalie
    Sleiman, Joseph
    Philpott, Jessica
    Funchain, Pauline
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S787 - S787
  • [9] Immune checkpoint inhibitors for refractory childhood cancers
    Widemann, Brigitte C.
    [J]. LANCET ONCOLOGY, 2020, 21 (01): : 14 - 15
  • [10] Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
    Alorfi, Nasser M.
    Alourfi, Mansour Marzouq
    [J]. BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 119 - 127
12345